We are live on ! Find out more
DMTK

DermTech, Inc. Common Stock

Delisted

DMTK was delisted on the 26th of June, 2024.

24 hedge funds and large institutions have $128M invested in DermTech, Inc. Common Stock in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 2

100% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 2

23% more capital invested

Capital invested by funds: $105M → $128M (+$23.9M)

9% more funds holding

Funds holding: 2224 (+2)

Holders
24
Holders Change
+2
Holders Change %
+9.09%
% of All Funds
0.55%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
8
Reduced
2
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HIM
26
HGC Investment Management
Ontario, Canada
-$2.92M -146,758 Closed

DMTK Hedge Fund Activity: Q3 2018 in Review

24 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in DermTech, Inc. Common Stock (DMTK) for Q3 2018, worth a combined $128M — up 23% from $105M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new DMTK positions and 2 closed out — a net gain of 2 holders — while 8 added to existing stakes and 2 trimmed.

The largest buyer was Westchester Capital Management (New York), adding an estimated $8.54M. The largest seller was Weiss Asset Management, exiting entirely with an estimated $5.17M sold.

  • 24 institutional investors held DermTech, Inc. Common Stock (DMTK) as of Q3 2018, up from 22 in Q2 2018.
  • Funds reported $128M of DermTech, Inc. Common Stock stock for Q3 2018, up 23% quarter-over-quarter.
  • 4 funds opened new DermTech, Inc. Common Stock positions in Q3 2018 and 2 closed out, a net change of +2 holders.
  • The largest DermTech, Inc. Common Stock buyer in Q3 2018 was Westchester Capital Management (New York), an estimated $8.54M added.
  • The largest DermTech, Inc. Common Stock seller in Q3 2018 was Weiss Asset Management, an estimated $5.17M sold.

Based on aggregated 13F filings for Q3 2018.